From Our Partners
Tuesday, July 5, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

Tauri Group Awarded JPEO-CBD Task Orders

by Global Biodefense Staff
September 11, 2014

The Tauri Group, LLC this week announced they have been awarded four task orders under the Medical Domain of the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) Omnibus Program Engineering and Technical Support (OPETS) contract.

OPETS is an indefinite delivery, indefinite quantity (IDIQ) contract with a maximum value of $495 million through December 2015.

Through these task orders, valued at $13 million over three years, The Tauri Group will provide the JPEO with bioengineers and medical advisors at Fort Belvoir, Fort Detrick, and Aberdeen Proving Ground. This builds on work currently provided to the Joint Product Manager BioDefense Therapeutics (JPdM-BDTx) program, where The Tauri Group has provided technical, programmatic, and medical scientific support since 2011.

“We are excited to continue providing the high-caliber support that JPEO has come to expect from The Tauri Group,” said Ben Hagar, The Tauri Group’s Program Manager. “With this work, we are contributing to a critical DoD program for protecting personnel from chemical and biological threats. This  opportunity to stay on the cutting edge of medical countermeasure development will further enhance our medical expertise, increasing our value to the Government and our partners.”

Source: The Tauri Group, LLC press release, adapted.

From Our Partners
Tags: JPEO-CBRND

Related Posts

Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC